Knowledge Distillery

Vaccines have represented the breakthrough in the fight against COVID-19. Based on reported headache attacks after vaccination in randomized…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) is frequently more severe in individuals with preexisting respiratory and…

Data on interruption of enzyme replacement therapy are scarce in late-onset Pompe disease. Due to the COVID-19 crisis, 8 neuromuscular reference…

The objective of this study was to descriptive analysis of COVID-19 infection in patients with multiple sclerosis (MS) receiving fingolimod or…

At present, delta variant is estimated to have caused more than 99% of COVID-19 infections worldwide; however, a new variant of concern, omicron…

The objective of this test negative case-control study was to evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 variants and…

To estimate the growth of the Omicron variant of concern and its immune escape characteristics, the authors analysed data from all PCR-confirmed…

The Omicron (B.1.1.529) variant of SARS-CoV-2 (severe acute respiratory syndrome coronavirus) was only recently detected in southern Africa, but its…

The emergence of Omicron (Pango lineage B.1.1.529), first identified in Botswana and South Africa, may compromise vaccine effectiveness and lead to…

The Delta variant is now the predominant circulating SARS-CoV-2 strain worldwide. Severity of illness in persons infected with the SARS-CoV-2 Delta…

Identifying and testing individuals likely to have SARS-CoV-2 is critical for infection control, including post-vaccination. Vaccination is a major…

Thrombosis with thrombocytopenia, or thrombocytopenia on its own, have been reported after COVID-19 vaccines. In this article the authors assessed the…